SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

2.

Young adults who are obese are at risk for 17 different types of cancer in the future.

3.

A study has developed molecular markers that predict meningioma recurrence.

4.

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

5.

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot